These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38898390)

  • 1. COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study.
    Pietroluongo E; Peddio A; De Placido P; Tortora M; Ottaviano M; Gelzo M; Cernera G; Foggia M; Buonomo AR; Pinchera B; Zappulo E; Mercinelli S; Cattaneo L; Sardanelli A; Viceconte G; Scotto R; Schiano Moriello N; Servetto A; De Angelis C; Arpino G; Palmieri G; De Placido S; Bianco R; Castaldo G; Gentile I; Giuliano M
    BMC Cancer; 2024 Jun; 24(1):748. PubMed ID: 38898390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response.
    Cernera G; Gelzo M; De Placido P; Ottaviano M; Pietroluongo E; Raia M; Scalia G; Tortora M; Castaldo G; Formisano P; Palmieri G; Giuliano M
    Front Immunol; 2023; 14():1233056. PubMed ID: 37705978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors.
    Pietroluongo E; De Placido P; Tortora M; Martinelli C; Viggiano A; Saponaro MR; Caltavituro A; Buonaiuto R; Morra R; Ottaviano M; Del Deo V; Cernera G; Gelzo M; Malfitano AM; Di Tolla MF; De Angelis C; Arpino G; Terracciano D; Bianco R; Veneziani BM; Formisano P; Castaldo G; Palmieri G; De Placido S; Giuliano M
    J Thorac Oncol; 2023 Oct; 18(10):1399-1407. PubMed ID: 37390981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors.
    Cernera G; Gelzo M; De Placido P; Pietroluongo E; Raia M; Scalia G; Tortora M; Formisano P; Palmieri G; Giuliano M; Castaldo G
    Clin Chem Lab Med; 2024 May; 62(6):1198-1205. PubMed ID: 38232092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis.
    Giugliano F; Zucali PA; Galli G; Ballatore Z; Corti C; Aliaga PT; Uliano J; Vivanet G; Curigliano G; Conforti F; Queirolo P; Berardi R; Manglaviti S; Apollonio G; Perrino M; Borea F; D'Antonio F; Garassino MC; De Pas T
    Eur J Cancer; 2022 May; 166():202-207. PubMed ID: 35306318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe COVID-19 pneumonia in Good syndrome with a favorable outcome.
    Cos Esquius ML; López Montesinos I; Gimeno Martinez R; Eguía Núñez J; Caballero-Rabasco MA; Sánchez González B; López García A; Mellibovsky L
    Clin Immunol; 2022 Feb; 235():108789. PubMed ID: 34197951
    [No Abstract]   [Full Text] [Related]  

  • 7. Long COVID-19 leading to Good's syndrome diagnosis: A clinical case-report and literature review.
    Tabarsi P; Hemmatian M; Moradi M
    Clin Case Rep; 2024 Jun; 12(6):e8962. PubMed ID: 38808198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic Epithelial Tumor-Associated Cytopenia: A 10-Year Observational Study in France.
    Rivoisy C; Besse B; Girard N; Lioger B; Viallard JF; Lega JC; Rullier P; Perlat A; Lerouge D; Clement-Duchene C; Ebbo M; Bosseray A; Godeau B; Lambotte O
    J Thorac Oncol; 2016 Mar; 11(3):391-9. PubMed ID: 26768832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patient with Good's syndrome and COVID-19. Report of a clinical case].
    Maldonado-Domínguez ED; O Farrill-Romanillos PM
    Rev Med Inst Mex Seguro Soc; 2022 Jul; 60(4):474-479. PubMed ID: 35819306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological signature of patients with thymic epithelial tumors and Good syndrome.
    Malfitano AM; D'Esposito V; De Placido P; Tortora M; Ottaviano M; Pietroluongo E; Morra R; Mucci B; Napolitano F; Montella L; Giuliano M; De Placido S; Terracciano D; Palmieri G; Formisano P
    Front Immunol; 2022; 13():908453. PubMed ID: 36059463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
    Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P;
    BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal SARS-CoV-2 infection in a male patient with Good's syndrome.
    Pozzi MR; Baronio M; Janetti MB; Gazzurelli L; Moratto D; Chiarini M; Plebani A; Lougaris V
    Clin Immunol; 2021 Feb; 223():108644. PubMed ID: 33301884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel.
    Marcus N; Frizinsky S; Hagin D; Ovadia A; Hanna S; Farkash M; Maoz-Segal R; Agmon-Levin N; Broides A; Nahum A; Rosenberg E; Kuperman AA; Dinur-Schejter Y; Berkun Y; Toker O; Goldberg S; Confino-Cohen R; Scheuerman O; Badarneh B; Epstein-Rigbi N; Etzioni A; Dalal I; Somech R
    Front Immunol; 2020; 11():614086. PubMed ID: 33519822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [COVID-19 in adults with antibody deficiencies].
    López AL; Torre MG; Paolini MV; Juri MC; Fernández Romero DS
    Medicina (B Aires); 2021; 81(3):478-481. PubMed ID: 34137714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the Natural History of Good's Syndrome: A Progressive Adult Combined Immunodeficiency.
    Kabir A; Polito V; Tsoukas CM
    J Allergy Clin Immunol Pract; 2024 Mar; 12(3):744-752.e3. PubMed ID: 38122866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Good
    Ren S; Hu Y; Xiao Y; Zong D; Peng Y; Liu Q; Jia Y; Ouyang R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 46(3):328-332. PubMed ID: 33927082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico.
    Castano-Jaramillo LM; Yamazaki-Nakashimada MA; O'Farrill-Romanillos PM; Muzquiz Zermeño D; Scheffler Mendoza SC; Venegas Montoya E; García Campos JA; Sánchez-Sánchez LM; Gámez González LB; Ramírez López JM; Bustamante Ogando JC; Vásquez-Echeverri E; Medina Torres EA; Lopez-Herrera G; Blancas Galicia L; Berrón Ruiz L; Staines-Boone AT; Espinosa-Padilla SE; Segura Mendez NH; Lugo Reyes SO
    J Clin Immunol; 2021 Oct; 41(7):1463-1478. PubMed ID: 34114122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COVID-19 in patients with Good syndrome: report of 4 cases and literature review].
    Yang LL; Huang LT; Ren SY; Ouyang RY
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 May; 47(5):430-436. PubMed ID: 38706064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.